CDER Emerging Drug Safety Technology Program

The Emerging Drug Safety Technology Program (EDSTP) is dedicated to the integration of artificial intelligence (AI) and emerging technologies within pharmacovigilance (PV) to advance drug safety and lifecycle management. This program fosters communication with the pharmaceutical industry to enhance the FDA’s understanding of AI-enabled tools and other technologies in PV, aiming to assess their performance, […]

Subscribe To AlvaMed's Newsletter

This field is for validation purposes and should be left unchanged.
A monthly analysis of the medical device industry, quality and regulatory developments, and other useful information for industry professionals. (Contact details are never shared outside our organization.)